HRV change scores during MM will be significantly higher in the CP and DA groups receiving MMA+ compared with corresponding CP and DA groups receiving MMA−, and will not differ between CF groups receiving MMA+ or MMA−. This evidence concerns the gene CP and cystic fibrosis.